Filing Details

Accession Number:
0001209191-10-024066
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-28 13:00:00
Reporting Period:
2010-04-27
Filing Date:
2010-04-28
Accepted Time:
2010-04-28 17:51:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266275 Kate Mitchell 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1279735 C Louis Bock 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1308328 Bavp, L.p. 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1308343 Scale Venture Management I, Llc 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1366969 Rory O'driscoll 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-27 1,649,358 $0.00 1,649,358 No 4 C Direct
Common Stock Acquisiton 2010-04-27 1,121,866 $0.00 2,771,224 No 4 C Direct
Common Stock Acquisiton 2010-04-27 1,153,719 $0.00 3,924,943 No 4 C Direct
Common Stock Acquisiton 2010-04-27 574,515 $0.00 4,499,458 No 4 C Direct
Common Stock Acquisiton 2010-04-27 363,636 $11.00 4,863,094 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2010-04-27 1,562,184 $0.00 1,649,358 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2010-04-27 1,121,866 $0.00 1,121,866 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2010-04-27 1,153,719 $0.00 1,153,719 $0.00
Common Stock Series C-1 Convertible Preferred Stock Disposition 2010-04-27 574,515 $0.00 574,515 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Automatic conversion, in connection with the Issuer's initial public offering, of 1,562,184 shares of Series A Preferred Stock into 1,649,358 shares of common stock.
  2. The shares are held by BAVP, LP ("BAVP"). The General Partner of BAVP is Scale Venture Management I, LLC ("Scale"). Louis Bock, Kate Mitchell, Rory O'Driscoll and Mark Brooks are managing members of Scale and share voting and investment power with respect to these shares. Each of the managing members of Scale disclaims beneficial ownership with respect to these shares except to the extent of their pecuniary interest therein.
  3. Automatic conversion, in connection with the Issuer's initial public offering, of Series B Preferred Stock at a rate of 1-for-1, resulting in the issuance of 1,121,866 shares of common stock.
  4. The Series B Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
  5. Automatic conversion, in connection with the Issuer's initial public offering, of Series C Preferred Stock at a rate of 1-for-1, resulting in the issuance of 1,153,719 shares of common stock.
  6. The Series C Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
  7. Automatic conversion, in connection with the Issuer's initial public offering, of Series C-1 Preferred Stock at a rate of 1-for-1, resulting in the issuance of 574,515 shares of common stock.
  8. The Series C-1 Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
  9. The securities are preferred stock of the Issuer and do not have an expiration date. The securities automatically converted into common stock upon the closing of the Issuer's initial public offering.